NextCODE Health was co-founded in 2013 by former deCODE genetics executives Jeffrey Gulcher and Hannes Smarason as a spinout from deCODE genetics after the latter was acquired by Amgen in December 2012. NextCODE Health is headquartered in Cambridge, Massachusetts, and has operations in Reykjavik, Iceland. The company has developed the world's most proven gene sequence analysis platform and the most efficient database architecture, enabling clinicians and researchers around the globe to use the full power of next-generation sequencing data to better diagnose and treat disease. The company's solutions combine the only whole genome analysis system developed at population scale with access to the largest clinical genetics reference database in the world.
View Top Employees from Nextcode CorporationWebsite | http://www.nextcode.com |
Revenue | $6 million |
Funding | $15 million |
Employees | View employees |
Address | 101 Main St, Fl 14, Cambridge, Massachusetts 02142, US |
Phone | (617) 712-1417 |
Industry | Software Development & Design, Software |
Competitors | Annai Systems, ArrayGen Technologies Private Limited, Immuneering Corporation, NeoMedia Technologies, Inc., Omixon |
SIC | SIC Code 581 Companies, SIC Code 58 Companies |
NAICS | NAICS Code 722 Companies, NAICS Code 722513 Companies, NAICS Code 72251 Companies, NAICS Code 7225 Companies, NAICS Code 72 Companies |
Looking for a particular Nextcode Corporation employee's phone or email?
The Nextcode Corporation annual revenue was $6 million in 2023.
Nextcode Corporation is based in Cambridge, Massachusetts.
The NAICS codes for Nextcode Corporation are [722, 722513, 72251, 7225, 72].
The SIC codes for Nextcode Corporation are [581, 58].